Answers are grounded in this paper and cite their sources.
Demonstrates gene silencing effects in breast cancer cell lines, indicating potential for angiogenesis treatment.
Small interferring RNA (siRNA) is a powerful tool for controlling cellular processes of gene silencing at post-transcriptional level due to its high sequence-specific inhibition efficiency. The aim of this study is to compare silencing effect of chitosan/shVEGF (shRNA-expressing plasmid DNA targeting vascular endothelial growth factor-A (VEGF-A)) nanoplexes between four different cell lines, two of which are MCF-7 and MDA-MB435 breast cancer cell lines. Nanoplexes were prepared using different concentrations. The morphological and physicochemical characterization were made and silencing activity of appropriate formulations were investigated in vitro. As a result of in vitro transfection studies made in different cell lines with nanoplexes in the different ratios, the highest gene inhibition (60%) was measured in MCF-7 after transfection while the lowest gene inhibition (29%) was observed in MDA-MB435. This work suggests that RNA interference has potential to be applied to delivery system studies and to the angiogenesis treatment.
No takes yet. Share an insight, caveat, or question.
Salva et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: